BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 19536074)

  • 21. Recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels.
    Kim JH; Kim JH; Yu YS; Kim DH; Kim KW
    J Neurosci Res; 2009 Feb; 87(3):653-9. PubMed ID: 18816791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
    Edelman JL; Lutz D; Castro MR
    Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation.
    Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
    Mol Vis; 2009 Sep; 15():1868-75. PubMed ID: 19756180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells.
    Villarroel M; García-Ramírez M; Corraliza L; Hernández C; Simó R
    Endocrinol Nutr; 2009 Feb; 56(2):53-8. PubMed ID: 19627712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity.
    Kim JH; Kim JH; Kim KW; Kim MH; Yu YS
    Nanotechnology; 2009 Dec; 20(50):505101. PubMed ID: 19923650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of a coumarin derivative in diabetic rats.
    Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
    Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
    J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
    Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
    Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
    Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
    Hofman P; Blaauwgeers HG; Tolentino MJ; Adamis AP; Nunes Cardozo BJ; Vrensen GF; Schlingemann RO
    Curr Eye Res; 2000 Aug; 21(2):637-45. PubMed ID: 11148600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation.
    Kim JH; Kim MH; Jo DH; Yu YS; Lee TG; Kim JH
    Biomaterials; 2011 Mar; 32(7):1865-71. PubMed ID: 21145587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Size-selective and in vitro assessment of inner blood retina barrier permeability.
    Campbell M; Humphries P
    Methods Mol Biol; 2011; 763():355-67. PubMed ID: 21874464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
    Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
    J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglia increase tight-junction permeability in coordination with Müller cells under hypoxic condition in an in vitro model of inner blood-retinal barrier.
    Inada M; Xu H; Takeuchi M; Ito M; Chen M
    Exp Eye Res; 2021 Apr; 205():108490. PubMed ID: 33607076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
    Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.